Dexcom's $320M Trading Volume Surges 45% Despite Stock Decline and Massive Recall
Volume AlertsWednesday, Jun 18, 2025 8:19 pm ET
1min readOn June 18, 2025, Dexcom's trading volume reached $320 million, marking a 45.09% increase from the previous day, ranking 237th in the day's stock market activity. Dexcom's stock price fell by 1.05%, marking the second consecutive day of decline, with a total decrease of 2.45% over the past two days.
Dexcom has issued a recall for its One+, One, G7, and G6 continuous glucose monitors (CGMs) due to potential issues with the receivers for these devices. The recall affects over 2 million CGM receivers, highlighting a significant concern for the company's product safety and reliability.
This recall is part of a broader issue with Dexcom's CGM receivers, which have been identified as a Class I recall. The affected systems include the
One and One+ offerings, as well as the G6 and G7 CGMs. This recall underscores the importance of addressing product defects promptly to maintain consumer trust and regulatory compliance.Disclaimer: The news articles available on this platform are generated in whole or in part by artificial intelligence and may not have been reviewed or fact checked by human editors. While we make reasonable efforts to ensure the quality and accuracy of the content, we make no representations or warranties, express or implied, as to the truthfulness, reliability, completeness, or timeliness of any information provided. It is your sole responsibility to independently verify any facts, statements, or claims prior to acting upon them. Ainvest Fintech Inc expressly disclaims all liability for any loss, damage, or harm arising from the use of or reliance on AI-generated content, including but not limited to direct, indirect, incidental, or consequential damages.
Comments
No comments yet